FDG PET/CT in a Case of Primary Angiosarcoma of the Kidney

Jian Yang1, Aisheng Dong1, Shensheng Nian2

  • 1From the Departments of Nuclear Medicine.

Clinical Nuclear Medicine
|January 30, 2023
PubMed

Insights

Primary kidney angiosarcoma is a rare cancer. This case study details its appearance on MRI and FDG PET/CT scans, including metastases to the liver, lungs, and bones.

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Primary angiosarcoma of the kidney is an exceptionally rare and aggressive malignancy.
  • Early diagnosis and characterization are crucial for effective management.

Observation:

  • This report details the magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) findings in a patient with primary renal angiosarcoma.
  • The primary renal tumor was large, exhibiting significant necrosis and increased FDG uptake in viable areas.

Findings:

  • FDG PET/CT successfully identified multiple metastatic lesions in the liver, lungs, and bones.
  • However, several hepatic metastases detected by MRI were not visualized on FDG PET/CT due to their low metabolic activity (low FDG avidity).

Implications:

  • This case highlights the utility of combined MRI and FDG PET/CT in evaluating primary renal angiosarcoma and its metastatic spread.
  • It also underscores the potential for FDG PET/CT to miss certain metastases, particularly in the liver, if they exhibit low fluorodeoxyglucose uptake, necessitating correlation with other imaging modalities like MRI.